Literature DB >> 8982055

A non-thrombocytopenic bleeding disorder due to an IgG4-kappa anti-GPIIb/IIIa autoantibody.

R McMillan1, R D Bowditch, P Tani, H Anderson, S Goodnight.   

Abstract

Autoantibodies in chronic immune thrombocytopenic purpura occasionally interfere with platelet function. We describe a patient with a normal platelet count who had clinically significant mucosal bleeding, a prolonged bleeding time and abnormal platelet aggregation. The patient had high titres of an IgG4 kappa autoantibody, directed to a cation-dependent epitope on platelet glycoprotein IIb/IIIa, which blocked the binding of fibrinogen and fibronectin to this complex. Corticosteroid treatment resulted in clinical improvement and a marked drop in autoantibody concentration. The lack of thrombocytopenia in this patient, despite high autoantibody levels, is best explained by the poor recognition of IgG4 antibodies by phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982055     DOI: 10.1046/j.1365-2141.1996.d01-1957.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Clinical significance of positive platelet immunofluorescence assay in adult immune thrombocytopenia.

Authors:  Nematollah Rostami; Soheila Borhani; Mahyar Khaledi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-11       Impact factor: 0.900

2.  Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals.

Authors:  A Ueki; Y Isozaki; A Tomokuni; T Hatayama; H Ueki; M Kusaka; M Shiwa; H Arikuni; T Takeshita; K Morimoto
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 3.  Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease.

Authors:  Monica Bacci; Antonietta Ferretti; Marina Marchetti; Maria A Alberelli; Anna Falanga; Corrado Lodigiani; Erica De Candia
Journal:  Blood Transfus       Date:  2022-01-08       Impact factor: 5.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.